Standard Care With LLLT & Myofascial Release Versus Standard Care Alone in Pregnant Women With Temporomandibular Disorder

November 18, 2021 updated by: Mohamed Magdy Ali Hassan ElMeligie, October 6 University

Standard Care Combined With Low-Level Laser Therapy and Myofascial Release Versus Standard Care Alone in Pregnant Women With Temporomandibular Disorder: A Randomized Controlled Trial

This study will investigate a novel approach to treat pregnant women with tempromandibular disorder using a combined method of low level laser therapy, myofascial release and standard care versus standard care alone. It's hopeful that the results of this study can fill the gap of knowledge surrounding the conservative treatment options for TMD in order to help patients restore their oral function properly and promote new ways of addressing TMD.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Giza
      • Al Ḩayy Ath Thāmin, Giza, Egypt, 12511
        • October 6 university hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women diagnosed with myofascial TMD according to the Research Diagnostic Criteria for Temporomandibular Disorders

Exclusion Criteria:

  • facial neuro-musculoskeletal pathologies (i.e., facial trauma and/or fractures, and bell's palsy)
  • acute infections or systemic disorders
  • osteoporosis
  • cervical spine or upper limb dysfunction
  • steroid infiltration4
  • any recent dental treatment taken or surgery over TMJ
  • hypermobile joint
  • neurological impairments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
Patients received a 4-week treatment program (12 treatment sessions, three times a week). Patients received the conservative treatment protocol comprised of ultrasound, hot pack application, and exercises.
  1. Ultrasound Participants will receive an application of pulsed ultrasound at a frequency of 3 MHz and an intensity of 0.5 W/cm² with a 1:1 duty cycle over TMJ for six minutes.
  2. Hot pack Participants will receive a warm water pack the TMJ and masticatory muscles for 10 minutes.
  3. Exercise program:

Active exercises for mandibular muscles will be used to correct the mouth opening

  1. Lateral movements of the jaw (3 sets of 10 repetitions).
  2. Jaw relaxation exercise (3 sets of 10 repetitions).
  3. Chin tuck (10 repetitions, holding 10s each).
  4. Resisted opening of the mouth (3 sets of 10 repetitions).
  5. Resisted closing of the mouth (3 sets of 10 repetitions).
  6. Stretching exercise for mandibular muscles.
Experimental: Intervention group
Patients received a 4-week treatment program (12 treatment sessions, three times a week). Patients received LLLT and myofascial release combined with the control intervention. the conservative treatment protocol comprised of ultrasound, hot pack application, and exercises
  1. Ultrasound Participants will receive an application of pulsed ultrasound at a frequency of 3 MHz and an intensity of 0.5 W/cm² with a 1:1 duty cycle over TMJ for six minutes.
  2. Hot pack Participants will receive a warm water pack the TMJ and masticatory muscles for 10 minutes.
  3. Exercise program:

Active exercises for mandibular muscles will be used to correct the mouth opening

  1. Lateral movements of the jaw (3 sets of 10 repetitions).
  2. Jaw relaxation exercise (3 sets of 10 repetitions).
  3. Chin tuck (10 repetitions, holding 10s each).
  4. Resisted opening of the mouth (3 sets of 10 repetitions).
  5. Resisted closing of the mouth (3 sets of 10 repetitions).
  6. Stretching exercise for mandibular muscles.
MLS® device (ASA Srl, Vicenza, Italy) IR laser with two synchronized sources (laser diodes) and a wavelength of 808 nm to deliver the intervention. The laser probe will be held vertically in contact with the skin to deliver the irradiation at three mandibular condyle points (front, behind and over) and one point at the external acoustic meatus. The irradiation will be applied with a laser bean of 3.14 cm² diameter for 14 seconds at each place using a pulse rate of 1500 Hz, pulse duration of 100ns, and energy density: 16 J/cm².
Patients will be positioned in supine in a treatment table. The therapist seated beside the patient at the side of affected temporomandibular joint to apply gross release technique for masseter, pterygoid and temporalis muscles. At each point, the therapist applied the technique for 90 seconds and repeated 5 times during the session (5 seconds of rest between each repetition).(15) The therapist worn gloves to deliver the intraoral myofascial release. In case the patient reported any latex allergies, the gloves were replaced by a latex free model.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in visual analogue scale
Time Frame: Baseline and after 4 weeks
Visual analog scale (VAS), a grading scale range from 0 to 100 mm. 0 mm represented no pain or discomfort at all and 100 mm represented the greatest amount of pain or discomfort imaginable. Participant drew a line that intersects the grading scale to show the amount of pain or discomfort that he or she experienced at that moment. The assessor then used a ruler to measure the length from 0 mm to the intersecting line and recorded the value.
Baseline and after 4 weeks
Changes in pain pressure threshold (PPT)
Time Frame: Baseline and after 4 weeks
Comparing pain pressure threshold differences on both sides over TMJ, masseter and anterior temporalis.
Baseline and after 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Limitations of daily function in temporomandibular disorder questionnaire
Time Frame: Baseline and after 4 weeks
The limitations in daily functions in the temporomandibular disorder questionnaire (LDF-TMDQ) assess participants' functionality by asking them to report how much the jaw problem prevents or limits their performance in a list of 10 daily activities
Baseline and after 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Radwa M Yehia, Ph.D, Faculty of Physical Therapy, October 6 University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2021

Primary Completion (Actual)

October 26, 2021

Study Completion (Actual)

October 26, 2021

Study Registration Dates

First Submitted

November 18, 2021

First Submitted That Met QC Criteria

November 18, 2021

First Posted (Actual)

December 1, 2021

Study Record Updates

Last Update Posted (Actual)

December 1, 2021

Last Update Submitted That Met QC Criteria

November 18, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all of the individual participant data collected during the trial and after deidentification

IPD Sharing Time Frame

6 Months after study publication

IPD Sharing Access Criteria

Email: mohamed.magdy.pt@o6u.edu.eg

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Disorder

Clinical Trials on Standard care

3
Subscribe